12:00 AM
 | 
Apr 23, 2012
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 4/20 cls
Endocyte Inc. (NASDAQ:ECYT) Baird Christopher Raymond Price target Neutral 95% $7.41
Leerink Howard Liang Price target Market perform
RBC Capital Markets Jason Kantor Price target Outperform
Raymond raised his target...

Read the full 496 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >